Frontlight ResearchEarly access
Trial site
UChicago Medicine Ingalls Memorial
- 5running trials
- 1closed trial
The trials here
What the 6 trials at this site are about, from their registry records.
- Conditions
- Bladder cancer2 trials
- Colorectal cancer2 trials
- Head and neck cancer2 trials
- Lung cancer2 trials
- Pancreatic cancer2 trials
- Cervical cancer1 trial
- Childhood cancers1 trial
- Gastric and oesophageal cancer1 trial
- Metastatic breast cancer1 trial
- Multiple myeloma1 trial
- Ovarian cancer1 trial
- Phase
- Phase 12 trials
- Phase 22 trials
- Phase 32 trials
- Status
- Active, not recruiting3 trials
- Recruiting2 trials
- Completed1 trial
- Lead sponsor
- Pfizer3 trials
- Seagen, a wholly owned subsidiary of Pfizer3 trials
Running trials
Active, not recruiting
Recruiting
A Study of Disitamab Vedotin Alone or With Pembrolizumab in Urothelial Cancer That Expresses HER2
Active, not recruiting
Recruiting
Active, not recruiting
Efficacy and Safety Study of Tisotumab Vedotin for Patients With Solid Tumors
Recruiting at the same time
How many trials recruit for the same indication here at once. A count, not a rating.
- Bladder cancer2 recruiting
- Cervical cancer1 recruiting
- Gastric and oesophageal cancer1 recruiting
- Head and neck cancer1 recruiting
- Lung cancer1 recruiting
- Ovarian cancer1 recruiting
- Pancreatic cancer1 recruiting
Closed trials
Site data: ClinicalTrials.govUpdated 12 Nov 2026